Showing results (31-40 of 250) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|February 26, 2004
In vitro activities of tigecycline against the Bacteroides fragilis groupN V Jacobus, L A McDermott, R Ruthazer, et al.
Bone Marrow Transplantation|August 26, 1998
Vancomycin-resistant enterococcal infections in bone marrow transplant recipientsY Koc, D R Snydman, D S Schenkein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, J Griffith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Attributable mortality of bacteremia associated with the Bacteroides fragilis groupM C Redondo, M D Arbo, J Grindlinger, et al.
The American Journal of Medicine|January 1, 1984
Hemophilus aphrophilus osteomyelitisJ L Ho, S Soukiasian, W H Oh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Spectrum and significance of bacteremia due to Moraxella catarrhalisJ P Ioannidis, M Worthington, J K Griffiths, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1980
Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapseG L Simon, D R Snydman, F P Tally, et al.
American Journal of Epidemiology|November 1, 1976
Hemodialysis-associated hepatitis: report of an epidemic with further evidence on mechanisms of transmissionD R Snydman, J A Bryan, E J Macon, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test resultsD R Snydman, N V Jacobus, L A McDermott, et al.
European Journal of Clinical Nutrition|February 3, 2011
Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trialL E Davidson, A-M Fiorino, D R Snydman, et al.
Pageof 25